Buprenorphine Extended-Release Injection and Resectisol
Determining the interaction of Buprenorphine Extended-Release Injection and Resectisol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: mannitol
Brand name: Osmitrol, Resectisol, Aridol
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Reserpine
- Buprenorphine Extended-Release Injection-Reserpine, hydralazine, and hydrochlorothiazide
- Buprenorphine Extended-Release Injection-Resinol topical
- Buprenorphine Extended-Release Injection-Resorcinol and sulfur Topical
- Buprenorphine Extended-Release Injection-Resorcinol topical
- Buprenorphine Extended-Release Injection-Respaire-30
- Resectisol-Buprenorphine implant
- Resectisol-Buprenorphine Injection
- Resectisol-Buprenorphine injection - Buprenex
- Resectisol-Buprenorphine injection - Sublocade
- Resectisol-Buprenorphine Intradermal
- Resectisol-Buprenorphine oral/buccal